資訊|論壇|病例

搜索

首頁(yè) 醫(yī)學(xué)論壇 專業(yè)文章 醫(yī)學(xué)進(jìn)展 簽約作者 病例中心 快問(wèn)診所 愛(ài)醫(yī)培訓(xùn) 醫(yī)學(xué)考試 在線題庫(kù) 醫(yī)學(xué)會(huì)議

您所在的位置:首頁(yè) > 內(nèi)分泌科診療指南 > 美國(guó)內(nèi)分泌學(xué)會(huì)原醛診療指南

美國(guó)內(nèi)分泌學(xué)會(huì)原醛診療指南

2014-04-14 20:38 閱讀:1583 來(lái)源:愛(ài)愛(ài)醫(yī) 作者:若****人 責(zé)任編輯:若你喜歡怪人
[導(dǎo)讀] Case Detection, Diagnosis, and Treatment of Patients with Primary Aldosteronism: An Endocrine Society Clinical Practice GuidelineObjective: Our objective was to develop clinical practice guidelines.

    《美國(guó)內(nèi)分泌學(xué)會(huì)原醛診療指南》內(nèi)容預(yù)覽:

    Evidence: Systematic reviews of available evidence were used to formulate the key treatment and prevention recommendations. We used the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) group criteria to describe both the quality of evidence and the strength of recommendations. We used “recommend” for strong recommendations and “suggest” for weak recommendations.

    Consensus Process: Consensus was guided by systematic reviews of evidence and discussions during one group meeting, several conference calls, and multiple e-mail communications. The drafts prepared by the task force with the help of a medical writer were reviewed successively by The Endocrine Society's CGS, Clinical Affairs Core Committee (CACC), and Council. The version approved by the CGS and CACC was placed on The Endocrine Society's Web site for comments by members. At each stage of review, the Task Force received written comments and incorporated needed changes.

    點(diǎn)擊下載***:《美國(guó)內(nèi)分泌學(xué)會(huì)原醛診療指南》


分享到:
  版權(quán)聲明:

  本站所注明來(lái)源為"愛(ài)愛(ài)醫(yī)"的文章,版權(quán)歸作者與本站共同所有,非經(jīng)授權(quán)不得轉(zhuǎn)載。

  本站所有轉(zhuǎn)載文章系出于傳遞更多信息之目的,且明確注明來(lái)源和作者,不希望被轉(zhuǎn)載的媒體或個(gè)人可與我們

  聯(lián)系z(mì)lzs@120.net,我們將立即進(jìn)行刪除處理

意見(jiàn)反饋 關(guān)于我們 隱私保護(hù) 版權(quán)聲明 友情鏈接 聯(lián)系我們

Copyright 2002-2024 Iiyi.Com All Rights Reserved